Article

Niwa, H., Masui, S., Chambers, I., Smith, A. G. & Miyazaki, J. Phenotypic complementation establishes requirements for specific POU domain and generic transactivation function of Oct-3/4 in embryonic stem cells. Mol. Cell. Biol. 22, 1526-1536

Stem Cell Regulation Research, Area of Molecular Therapeutics, Course of Advanced Medicine, Osaka University Graduate School of Medicine, Suita C, Osaka 565-0871, Japan.
Molecular and Cellular Biology (Impact Factor: 5.04). 04/2002; 22(5):1526-36. DOI: 10.1128/MCB.22.5.1526-1536.2002
Source: PubMed

ABSTRACT Transcription factors of the POU family govern cell fate through combinatorial interactions with coactivators and corepressors. The POU factor Oct-3/4 can define differentiation, dedifferentation, or self-renewal of pluripotent embryonic stem (ES) cells in a sensitive, dose-dependent manner (H. Niwa, J.-I. Miyazali, and A. G. Smith, Nat. Genet. 24:372-376, 2000). Here we have developed a complementation assay based on the ability of Oct-3/4 transgenes to rescue self-renewal in conditionally null ES cells and used this to define which domains of Oct-3/4 are required to sustain the undifferentiated stem cell phenotype. Surprisingly, we found that molecules lacking either the N-terminal or C-terminal transactivation domain, though not both, can effectively replace full-length Oct-3/4. Furthermore, a fusion of the heterologous transactivation domain of Oct-2 to the Oct-3/4 POU domain can also sustain self-renewal. Thus, the unique function of Oct-3/4 in ES cell propagation resides in combination of the specific POU domain with a generic proline-rich transactivation domain. Interestingly, however, Oct-3/4 target gene expression elicited by the N- and C-terminal transactivation domains is not identical, indicating that at least one class of genes activated by Oct-3/4 is not required for ES cell propagation.

Download full-text

Full-text

Available from: Jun-ichi Miyazaki, Jan 10, 2014
1 Follower
 · 
112 Views
  • Source
    • "Immunophenotypic characterization of both cell types demonstrated the presence of the common, well-defined human mesenchymal stem cell markers CD90, CD44, CD73, CD166, CD105, CD29, CD13, CD49e, CD54, as well as the embryonic stem-cell markers TRA-1-60, TRA-1-81, SSEA-3 and -4 and STRO-1 (Bilic et al. 2008; Díaz- Prado et al. 2010; Stadler et al. 2008). In addition, amniotic epithelial cells express Oct-4 and Nanog, two transcription factors known to be required for selfrenewal and pluripotency (Niwa et al. 2002; Chambers et al. 2003). Unlike human embryonic stem cells, amnion epithelial cells do not express telomerase and are nontumorigenic upon transplantation. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Amniotic membrane (AM) is the innermost, multilayered part of the placenta. When harvested, processed and stored properly, its properties, stemming from AM biological composition, make it a useful tissue for ophthalmic surgery. AM was shown to have several beneficial effects: it promotes epithelization, has antimicrobial effects, decreases inflammation, fibrosis and neovascularization. Many case reports and case series as well as practical experience (e.g. reconstruction of conjunctival and corneal defects, treatment of corneal ulcers) demonstrated the beneficial effect of AM for different ophthalmological indications. The combination of the above mentioned beneficial effects and reasonable mechanical properties are also the reason why AM is used as a substrate for ex vivo expansion of epithelial progenitor cells. Recently, amnion-derived cells, which also have stem cell characteristics, have been proposed as potential contributors to cell-based treatment of ocular surface disease. However, the use of AM remains one of the least standardized methods in ophthalmic surgery. In this review, the various properties of AM and its current clinical use in ophthalmology in Slovenia are discussed.
    Cell and Tissue Banking 12/2013; 15(2). DOI:10.1007/s10561-013-9417-6 · 1.03 Impact Factor
  • Source
    • "Twenty-four to forty-eight hours after transfection, the cells were collected and lysed, and luciferase assay was performed with the Dual-Luciferase Reporter Assay System (Promega). Reporter plasmids were a kind gift from Professor Hitoshi Niwa (Riken Institute, Japan) (Niwa et al., 2002). The expression vector used was the pCAG-IP plasmid. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Oct4 is an essential regulator of pluripotency in vivo and in vitro in embryonic stem cells, as well as a key mediator of the reprogramming of somatic cells into induced pluripotent stem cells. It is not known whether activation and/or repression of specific genes by Oct4 is relevant to these functions. Here, we show that fusion proteins containing the coding sequence of Oct4 or Xlpou91 (the Xenopus homolog of Oct4) fused to activating regions, but not those fused to repressing regions, behave as Oct4, suppressing differentiation and promoting maintenance of undifferentiated phenotypes in vivo and in vitro. An Oct4 activation domain fusion supported embryonic stem cell self-renewal in vitro at lower concentrations than that required for Oct4 while alleviating the ordinary requirement for the cytokine LIF. At still lower levels of the fusion, LIF dependence was restored. We conclude that the necessary and sufficient function of Oct4 in promoting pluripotency is to activate specific target genes.
    Cell Reports 02/2012; 1(2):99-109. DOI:10.1016/j.celrep.2011.12.002 · 8.36 Impact Factor
  • Source
    • "Indeed, most of maternal mutant (M) spg embryos and MZ embryos rescued by Pou5f1 mRNA injection develop normally, despite the vastly different Pou5f1 activity levels in these embryos. This situation apparently differs from the mode of Pou5f1 action in ES cells, where the levels of Pou5f1/Oct4 need to be precisely tuned (Niwa et al., 2000, 2002). However, the situation in the later stages of mammalian development, that is, in the pluripotent epiblast cells after implantation, may be different and it would be interesting to test, whether the zebrafish model regulatory scenario fits to the expression of double Pou5f1 and SoxB1 targets in these systems. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Gastrulation in vertebrates is a conserved process, which involves transition from cellular pluripotency to early precursors of ectoderm, mesoderm, and endoderm. Pluripotency control during this stage is far from being understood. Recent genetic and transcriptomic studies in zebrafish suggest that the core pluripotency transcription factors (TFs) Pou5f1 and TFs of the SoxB1 group are critically involved in large-scale temporal coordination of gene expression during gastrulation. A significant number of evolutionary conserved target genes of Pou5f1 in zebrafish are also involved in stem-cell circuit in mammalian ES cell cultures. Here, I will review the roles of Pou5f1 in development and discuss the evolutionary conservation of Pou5f1 functions and their relation to pluripotency control.
    genesis 02/2012; 50(2):75-85. DOI:10.1002/dvg.20800 · 2.04 Impact Factor
Show more

Similar Publications